FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3147015387> ?p ?o ?g. }

• W3147015387 abstract "Abstract Background Fatigue is a key symptom in patients with systemic lupus erythematosus (SLE), and regulatory bodies recommend its assessment in clinical trials of SLE therapies. Methods This post hoc pooled analysis of the three BeLimumab In Subjects with Systemic lupus erythematosus (BLISS) Phase 3 randomised, double-blind, parallel-group controlled trials evaluated the measurement properties of the Functional Assessment of Chronic Illness Therapy (FACIT)-Fatigue. Patients ( N = 2520) completed the FACIT-Fatigue every 4 weeks from baseline until the end of each study period. Internal consistency, test–retest reliability, convergent validity, and ability to detect changes in SLE were evaluated for the FACIT-Fatigue. Results The FACIT-Fatigue showed good internal consistency reliability (Cronbach’s alpha > 0.90), very good test–retest reliability (0.76 ≤ intraclass correlation coefficient ≤ 0.92), and moderate-strong convergent validity (0.49 ≤ |r| ≤ 0.86) against scale and summary measure scores from the Short Form 36 Health Survey Version 2. Correlations between FACIT-Fatigue and British Isles Lupus Assessment Group (BILAG) General/Musculoskeletal scores (0.24 ≤ |r| ≤ 0.43) supported convergent validity. Correlations between FACIT-Fatigue and the Safety of Estrogens in Lupus Erythematosus National Assessment-Systemic Lupus Erythematosus Disease Activity Index (SELENA-SLEDAI) scores and SLE annualised flare rate were weak but in the expected direction (ranging from − 0.02 to − 0.25). Known-groups validity testing showed that the FACIT-Fatigue can significantly discriminate between patient groups with differing scores for SELENA-SLEDAI, BILAG (General and Musculoskeletal) ratings, and Physician’s Global Assessment (PGA). Patients showing improvement in PGA and meeting the BILAG responder criteria had significantly higher mean improvement in FACIT-Fatigue scores than those without improvements in either measure (Week 52 mean score difference [95% confidence interval]: − 4.0 [− 5.0, − 3.0] and −2.2 [−3.1, −1.2], respectively; both p < 0.0001). The range of important (i.e. meaningful) change in FACIT-Fatigue, based on multiple anchors, was 3–6 points. Conclusions The FACIT-Fatigue demonstrated adequate psychometric properties in patients with SLE. The body of evidence from the three BLISS trials (both pooled and individually) supports the FACIT-Fatigue as a reliable and valid measure of SLE-related fatigue in clinical trials. Clinical trial identifiers BLISS-SC (NCT01484496), BLISS-52 (NCT00424476), and BLISS-76 (NCT00410384)." @default.
• W3147015387 created "2021-04-13" @default.
• W3147015387 creator A5000850747 @default.
• W3147015387 creator A5035791734 @default.
• W3147015387 creator A5086574285 @default.
• W3147015387 creator A5086818295 @default.
• W3147015387 creator A5086907959 @default.
• W3147015387 date "2021-04-08" @default.
• W3147015387 modified "2023-09-27" @default.
• W3147015387 title "Psychometric properties of FACIT-Fatigue in systemic lupus erythematosus: a pooled analysis of three phase 3 randomised, double-blind, parallel-group controlled studies (BLISS-SC, BLISS-52, BLISS-76)" @default.
• W3147015387 cites W1964233187 @default.
• W3147015387 cites W1985446631 @default.
• W3147015387 cites W2003882616 @default.
• W3147015387 cites W2005219432 @default.
• W3147015387 cites W2038847251 @default.
• W3147015387 cites W2046330020 @default.
• W3147015387 cites W2057591576 @default.
• W3147015387 cites W2068881653 @default.
• W3147015387 cites W2073997771 @default.
• W3147015387 cites W2095666655 @default.
• W3147015387 cites W2101867353 @default.
• W3147015387 cites W2129375743 @default.
• W3147015387 cites W2131457901 @default.
• W3147015387 cites W2136149088 @default.
• W3147015387 cites W2151120833 @default.
• W3147015387 cites W2157968254 @default.
• W3147015387 cites W2606822855 @default.
• W3147015387 cites W2753055890 @default.
• W3147015387 cites W2759755664 @default.
• W3147015387 cites W2775607224 @default.
• W3147015387 cites W2908459891 @default.
• W3147015387 cites W4255713912 @default.
• W3147015387 doi "https://doi.org/10.1186/s41687-021-00298-x" @default.
• W3147015387 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8032841" @default.
• W3147015387 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33830377" @default.
• W3147015387 hasPublicationYear "2021" @default.
• W3147015387 type Work @default.
• W3147015387 sameAs 3147015387 @default.
• W3147015387 citedByCount "1" @default.
• W3147015387 countsByYear W31470153872022 @default.
• W3147015387 crossrefType "journal-article" @default.
• W3147015387 hasAuthorship W3147015387A5000850747 @default.
• W3147015387 hasAuthorship W3147015387A5035791734 @default.
• W3147015387 hasAuthorship W3147015387A5086574285 @default.
• W3147015387 hasAuthorship W3147015387A5086818295 @default.
• W3147015387 hasAuthorship W3147015387A5086907959 @default.
• W3147015387 hasBestOaLocation W31470153871 @default.
• W3147015387 hasConcept C104709138 @default.
• W3147015387 hasConcept C106906290 @default.
• W3147015387 hasConcept C121244757 @default.
• W3147015387 hasConcept C126322002 @default.
• W3147015387 hasConcept C159654299 @default.
• W3147015387 hasConcept C170286685 @default.
• W3147015387 hasConcept C171606756 @default.
• W3147015387 hasConcept C1862650 @default.
• W3147015387 hasConcept C203014093 @default.
• W3147015387 hasConcept C2775915377 @default.
• W3147015387 hasConcept C2776912625 @default.
• W3147015387 hasConcept C2778453870 @default.
• W3147015387 hasConcept C2779134260 @default.
• W3147015387 hasConcept C2781205201 @default.
• W3147015387 hasConcept C3018868096 @default.
• W3147015387 hasConcept C70410870 @default.
• W3147015387 hasConcept C71924100 @default.
• W3147015387 hasConceptScore W3147015387C104709138 @default.
• W3147015387 hasConceptScore W3147015387C106906290 @default.
• W3147015387 hasConceptScore W3147015387C121244757 @default.
• W3147015387 hasConceptScore W3147015387C126322002 @default.
• W3147015387 hasConceptScore W3147015387C159654299 @default.
• W3147015387 hasConceptScore W3147015387C170286685 @default.
• W3147015387 hasConceptScore W3147015387C171606756 @default.
• W3147015387 hasConceptScore W3147015387C1862650 @default.
• W3147015387 hasConceptScore W3147015387C203014093 @default.
• W3147015387 hasConceptScore W3147015387C2775915377 @default.
• W3147015387 hasConceptScore W3147015387C2776912625 @default.
• W3147015387 hasConceptScore W3147015387C2778453870 @default.
• W3147015387 hasConceptScore W3147015387C2779134260 @default.
• W3147015387 hasConceptScore W3147015387C2781205201 @default.
• W3147015387 hasConceptScore W3147015387C3018868096 @default.
• W3147015387 hasConceptScore W3147015387C70410870 @default.
• W3147015387 hasConceptScore W3147015387C71924100 @default.
• W3147015387 hasIssue "1" @default.
• W3147015387 hasLocation W31470153871 @default.
• W3147015387 hasLocation W31470153872 @default.
• W3147015387 hasLocation W31470153873 @default.
• W3147015387 hasOpenAccess W3147015387 @default.
• W3147015387 hasPrimaryLocation W31470153871 @default.
• W3147015387 hasRelatedWork W2089003843 @default.
• W3147015387 hasRelatedWork W2109422742 @default.
• W3147015387 hasRelatedWork W2138415608 @default.
• W3147015387 hasRelatedWork W2257260161 @default.
• W3147015387 hasRelatedWork W2560693534 @default.
• W3147015387 hasRelatedWork W2884501713 @default.
• W3147015387 hasRelatedWork W2959678203 @default.
• W3147015387 hasRelatedWork W3047890441 @default.
• W3147015387 hasRelatedWork W4379094334 @default.
• W3147015387 hasRelatedWork W4385629523 @default.
• W3147015387 hasVolume "5" @default.
• W3147015387 isParatext "false" @default.
• W3147015387 isRetracted "false" @default.

• next